utilizing flt3 inhibitors in relapsed/refractory aml
Published 5 years ago • 89 plays • Length 4:13Download video MP4
Download video MP3
Similar videos
-
6:38
relapsed/refractory flt3-mutated aml
-
7:26
targeting flt3 in patients with relapsed/refractory aml
-
5:07
relapsed vs. refractory data for flt3 inhibitors in aml
-
2:28
dr. levis on gilteritinib in relapsed/refractory flt3-mutated aml
-
4:06
utilization of second-generation flt3 inhibitors in aml
-
4:47
the use of flt3 inhibitors in aml
-
4:05
optimizing use of flt3 inhibitor therapy for aml
-
1:06
gilteritinib monotherapy shows potential for treatment of relapsed/refractory flt3 aml
-
1:09
dr. altman on gilteritinib in patients with relapsed/refractory aml
-
5:45
clinical trials in aml: frontline use of flt3 inhibitors
-
3:18
second-generation flt3 inhibitors in aml
-
5:49
emerging flt3 inhibitors in aml
-
4:48
aml studies: flt3 inhibitors
-
1:59
optimizing the use of flt3 inhibitors in aml: sequencing, post-transplant maintenance & more
-
4:05
long-term challenges with flt3 inhibition in aml
-
1:37
emerging mutations at relapse in flt3-mutated r/r aml on gilteritinib
-
1:20
dr. olin on flt3 inhibitor research in aml
-
6:51
aml on the go - selective inhibition of flt3 by gilteritinib
-
1:12
the value of flt3 inhibitors in aml and focus for future trial designs